Neurocrine biosciences, inc. appoints david w. boyer as chief corporate affairs officer

Neurocrine biosciences, inc. announced that david w. boyer has joined the company's executive management team as chief corporate affairs officer. boyer joins neurocrine biosciences from bgr group, where he served as a principal and head of the health & lifesciences practice, leading the firm's healthcare advocacy, policy and strategy development, and strategic consulting team. in his new role at neurocrine biosciences, boyer will be responsible for patient advocacy and engagement, corporate communications, government relations, and public policy. boyer brings nearly 20 years of experience in public affairs, specializing in the life sciences and biopharmaceutical sectors. during his tenure at bgr group, he led public policy, advocacy and strategic communications initiatives for a wide range of healthcare clients. prior to joining bgr group, boyer served as special assistant to the president for legislative affairs under president george w. bush, assistant commissioner for legislation at the u.s. food and drug administration, and special assistant to the secretary at the u.s. department of health and human services. in addition to his public service, he held senior advocacy positions at the biotechnology innovation organization (bio) and the pharmaceutical research and manufacturers of america (phrma). boyer holds a bachelor of arts in government from georgetown university.
NBIX Ratings Summary
NBIX Quant Ranking